Mar 12, 2024 · M2GEN today announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson …

Clayton Dubilier & Rice (“CD&R” or the “Firm”) today announced that it has entered into a definitive agreement for funds it manages to acquire Shearer’s Foods (“Shearer’s” or the …

Cloudera, (NYSE: CLDR), the enterprise data cloud company, today announced that it has entered into a definitive agreement to be acquired by affiliates of Clayton, Dubilier & Rice …

Clayton, Dubilier & Rice today announced the closing of CD&R funds’ acquisition of Epicor, a global provider of industry-specific enterprise software to industrial sectors.

Aug 2, 2017 · Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an …

Mr. Volpe joined CD&R in 2008 and is principally engaged in evaluating investment opportunities. He played a key role in the Firm’s acquisition of John Deere Landscapes and investment in …

Mr. Zrebiec joined CD&R in 2004. He has played a key role in the execution of several of the Firm’s transactions, including the investments in Atkore International, Brand Energy and …

May 21, 2014 · Clayton, Dubilier & Rice ("CD&R" or "the Firm") today announced the appointment of John Hayes, former Chairman and CEO of Ball Corporation, as an Operating Advisor to …

Mr. Herbst joined the Firm’s London office in 2006. He plays a key role in several of the Firm’s investments, including B&M Retail and BCA. Previously, he worked for Duke Street Capital, …

Throughout his 20 years at CD&R, Mr. Conway has been active in a number of the Firm’s investments and organizational initiatives and works closely with the Chief Executive Officer …